Stock Research: Elevance Health

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Elevance Health

NYQ:ELV US0367521038
83
  • Value
    91
  • Growth
    17
  • Safety
    Safety
    83
  • Combined
    81
  • Sentiment
    85
  • 360° View
    360° View
    83
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Elevance Health, Inc. is a health company operating as a health insurer. It operates in the health insurance industry through Health Benefits, CarelonRx, and Carelon Services. It operates in the United States. In the last fiscal year, the company had a market cap of $75,961 million.

more

ANALYSIS: With an Obermatt 360° View of 83 (better than 83% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Elevance Health are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Elevance Health. The consolidated Value Rank has an attractive rank of 91, which means that the share price of Elevance Health is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 91% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 83. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 85. But the consolidated Growth Rank has a low rank of 17, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 83 of its competitors have better growth. ...read more

more
Index
D.J. US Health Care
S&P 500
Renewables Users
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
91 85 80 73
Growth
17 18 25 95
Safety
Safety
83 41 41 41
Sentiment
85 31 90 95
360° View
360° View
83 88 88 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
40 48 76 60
Opinions Change
50 7 50 48
Pro Holdings
n/a 25 88 97
Market Pulse
100 88 67 82
Sentiment
85 31 90 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
91 85 80 73
Growth
17 18 25 95
Safety Safety
83 41 41 41
Combined
81 96 96 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
79 66 67 69
Price vs. Earnings (P/E)
67 72 77 53
Price vs. Book (P/B)
71 53 33 37
Dividend Yield
93 85 78 78
Value
91 85 80 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
10 61 18 63
Profit Growth
89 28 54 67
Capital Growth
39 24 28 60
Stock Returns
21 21 35 89
Growth
17 18 25 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
66 44 54 52
Refinancing
89 64 64 64
Liquidity
61 73 70 64
Safety Safety
83 41 41 41

Similar Stocks

Discover high‑ranked alternatives to Elevance Health and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Resideo Technologies

NYQ:REZI
Country: USA
Industry: Building Products
Size: Large
Full Stock Analysis

Peabody Energy

NYQ:BTU
Country: USA
Industry: Coal & Consumable Fuels
Size: Large
Full Stock Analysis

Innoviva

NSQ:INVA
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: